Pneumoconiosis Treatment

Pneumoconiosis treatment

Alternative Pneumoconiosis Treatment Offered at the Lung Institute

Common pneumoconiosis treatment options include medications, lifestyle changes and activity modifications. Even though this condition, which is also known as black lung disease, cannot be cured, many people are able to manage their symptoms by using supplemental oxygen, taking prescription medications to keep their lung passages open and avoiding tobacco products and dust exposure.

A newer, innovative pneumoconiosis treatment option is stem cell therapy, in which a patient’s own stem cells are used to help reduce inflammation and promote healing. Unlike some other treatments, stem cell therapy has the potential to slow the progression of the disease. Many people who undergo stem cell treatment for pneumoconiosis report not only an improvement in their quality of life, but also a reduced dependence on medications and supplemental oxygen.

At the Lung Institute, we offer two types of stem cell therapy as pneumoconiosis treatment. These therapies work in similar ways, with the primary difference being the source of the stem cells. In our venous stem cell procedure, the cells are taken from the patient’s blood. In our bone marrow procedure, the cells are taken from the patient’s bone marrow. Both autologous stem cell procedures are performed on an outpatient basis over the course of two days and consist of three simple steps:

  • Our experienced medical professionals take a blood or bone marrow sample from the patient
  • In our onsite lab, we separate out the stem cells, which are uniquely capable of promoting healing, from the rest of the blood or bone marrow’s components
  • We return the concentrated stem cells to the patient’s body, and after a short monitoring period, the patient can return to the hotel accommodations

We are committed to helping each patient achieve the best possible outcome for his or her pneumoconiosis treatment. After the procedure, our medical team conducts comprehensive follow-up care and coordinates with the other members of the patient’s treatment team, including his or her primary care physician and pulmonologist.

For more information about stem cell therapy as an alternative pneumoconiosis treatment, or for more facts about black lung disease, call the Lung Institute at (800) 729-3065. Our dedicated staff can help you determine if stem cell treatment may be right for you.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.